MetaCap

Editas Medicine (EDIT) vs Eikon Therapeutics (EIKN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Eikon Therapeutics is the larger company by market cap ($256.8 million vs $253.1 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EDIT-1.50%EIKN-68.40%
+135%+28%-78%
Feb 5, 20261 yearNov 20, 2026
EDIT-9.89%EIKN-67.31%
+109%+17%-76%
Feb 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EDIT versus EIKN key metrics
MetricEDITEIKN
Share price$1.64$4.74
Market cap$253.12M$256.84M
1-day change-4.09%-0.42%
YTD return-20.00%—
1-year return-32.23%—
5-year return-94.93%—
EPS (TTM)$-0.54$-7.86
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$40.52M—
Revenue growth (YoY)+25.39%—
Net income (latest FY)$-160.06M—
Operating margin-394.89%—
Net margin-395.01%—
52-week high$3.94$17.40
52-week low$1.63$4.72
Distance from 52-week high-58.38%-72.76%
Analyst consensusbuybuy
Avg. price target upside+271.95%+406.33%
Average volume2.63M560.40K
Shares outstanding154.34M54.19M
Employees87384
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Editas Medicine

EDIT stock →

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 87 employees

About Eikon Therapeutics

EIKN stock →

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 384 employees

EDIT vs EIKN FAQ

Which is bigger, Editas Medicine or Eikon Therapeutics?

Eikon Therapeutics (EIKN) is larger, with a market capitalization of $256.84M compared with $253.12M for Editas Medicine (EDIT).

Are Editas Medicine and Eikon Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons